# Nuclear Imaging Equipment Devices Market > Nuclear Imaging Equipment Devices Market Research Report Information By Product (SPECT Imaging Systems (Hybrid SPECT Imaging Systems, Standalone SPECT Imaging Systems), PET Imaging Systems, and Planar Scintigraphy Imaging Systems), By Application (Oncology, Cardiology, Neurology, and Other Application), By End-User (Hospitals, Imaging Centers, Academic & Research Centers, and Other End Users), By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.5% - **2024:** $ 3.11 Billion - **2025:** $ 3.28 Billion - **2035:** $ 5.61 Billion - **Key Players:** GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Elekta (SE), Medtronic (US), Hitachi Medical Corporation (JP), Bracco Imaging (IT) **Report ID:** MRFR/HC/14543-HCR · **Pages:** 128 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** May 15, 2026 **URL:** https://www.marketresearchfuture.com/reports/nuclear-imaging-equipment-devices-market-16070 --- ## Market Summary ## **Global Nuclear Imaging Equipment Devices Market Overview ** As per MRFR analysis, the Nuclear Imaging Equipment Devices Market Size was estimated at 3.11 (USD Billion) in 2024. The Nuclear Imaging Equipment Devices Market Industry is expected to grow from 3.28 (USD Billion) in 2025 to 5.32 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 5.50% during the forecast period (2025 - 2034). The growing emphasis on customized medications and advancements in radiotracers are the main market drivers of nuclear imaging equipment devices market revenue growth. Additionally, the expansion of the pharmaceutical sector and the increased incidence of long-term illnesses like cancer would boost market expansion. Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review ## **Nuclear Imaging Equipment Devices Market Trends** The market for nuclear imaging equipment devices is anticipated to rise as chronic diseases become more common. In the United States, one in four persons had two or more chronic health issues, and over 117 million people suffered from at least one chronic health condition, according to a 2012 report from the Center for Chronic Disease Prevention and Health Promotion. Furthermore, the World Health Organization (WHO) projects that by 2020, chronic illnesses will be responsible for about three-quarters of all fatalities ly. According to WHO estimates, 71% of these deaths will be from Ischaemic Heart Disease (IHD) and 75% from stroke. Over the course of the forecast period, rising applications for nuclear imaging equipment devices due to technical developments, nuclear imaging equipment development, and the shift from standalone to hybrid modalities for diagnostic purposes are likely to fuel market expansion. Further propelling market expansion will be government support for research and development initiatives aimed at creating new technologies in the healthcare sector. The market will have growth prospects due to the increasing awareness of the importance of early diagnosis and the development of new radiopharmaceuticals. Furthermore, an increasing trend in demand for data integrated imaging systems is expected to drive market expansion. ly, data integrated imaging systems are being used by hospitals and physicians to create three-dimensional images and obtain extensive information on a patient's diagnostic history. Over the past ten years, hybrid systems have evolved significantly due to developments in imaging technology. The use of integrated PET modalities represents a significant improvement in this area. The major imaging system manufacturers no longer offer standalone PET systems due to the popularity of the PET/CT modality innovation. The success of the hybrid PET/CT systems has drawn interest in hybrid PET/MRI and SPECT/CT systems as well. Compared to standalone systems, these hybrid systems may provide exact images with higher resolution. They can offer both physiological and morphological details in a single evaluation. For instance, a SPECT/CT system improves the specificity of the information obtained by CT while also providing correct localization in the context of skeletal examination. Owing to benefits like these, a growing number of hospitals are switching from standalone to hybrid systems. The market for nuclear imaging equipment devices is expected to develop as a result of the growing acceptance of hybrid modalities. Thus, driving the nuclear imaging equipment devices market revenue. ## **Nuclear Imaging Equipment Devices Market Segment Insights** ### **Nuclear Imaging Equipment Devices Product Insights** The  nuclear imaging equipment devices market segmentation, based on product includes SPECT Imaging Systems (Hybrid SPECT Imaging Systems, Standalone SPECT Imaging Systems), PET Imaging Systems, and Planar Scintigraphy Imaging Systems. The SPECT imaging systems segment dominated the market since the transition from solo to hybrid modalities is being driven by technical improvements. These hybrid technologies offer high-resolution, exact images that include physiological and morphological details. ### **Nuclear Imaging Equipment Devices Application Insights** The  nuclear imaging equipment devices market segmentation, based on application, includes Oncology, Cardiology, Neurology, and Other Application. The oncology category generated the most income because the frequency of cancers is increasing. Additionally, an upward trend in the segment's growth is anticipated because of the growing number of activities from both public and private entities to expand the use of radiotracers and advanced systems in oncology. ### **Nuclear Imaging Equipment Devices End-User Insights** The  nuclear imaging equipment devices market segmentation, based on end-user, includes Hospitals, Imaging Centers, Academic & Research Centers, and Other End Users. The hospitals category generated the most income because improved nuclear imaging technologies have been widely adopted. Furthermore, higher government spending on hospitals during the COVID-19 crisis is blamed for the segment's development. **Figure 1:  Nuclear Imaging Equipment Devices Market, by End-User, 2022 & 2032 (USD Billion)** **** Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review ### **Nuclear Imaging Equipment Devices Regional Insights** By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American nuclear imaging equipment devices market area will dominate this market. This is because more people are using new imaging technology, which should lead to better cancer therapy and higher-quality images. For instance, the nanoScan PET/MRI 3T preclinical in vivo imaging system was deployed in October 2018 by the Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI), University of Utah, to screen rodent tumor models. Moreover, over the projection period, it is anticipated that the rising incidence of cancer in North America will fuel demand for nuclear imaging equipment devices. Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil. **Figure 2:  NUCLEAR IMAGING EQUIPMENT DEVICES MARKET SHARE BY REGION 2022 (USD Billion)** **** Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review Europe nuclear imaging equipment devices market accounts for the second-largest market share due to the increased application of nuclear imaging equipment devices and the introduction of new radiopharmaceuticals for medical diagnosis. Furthermore, technological advancements combined with advancements in the healthcare sector are expected to further push the market's rise for nuclear imaging equipment devices in the region. Further, the German nuclear imaging equipment devices market held the largest market share, and the UK nuclear imaging equipment devices market was the fastest growing market in the European region The Asia-Pacific Nuclear Imaging Equipment Devices Market is expected to grow at the fastest CAGR from 2023 to 2032 due to the increasing prevalence of chronic illnesses, expanding knowledge of the advantages of early disease detection, and enhanced healthcare infrastructure in the area, all of which contribute to the market expansion for nuclear imaging equipment devices. Moreover, China’s nuclear imaging equipment devices market held the largest market share, and the Indian nuclear imaging equipment devices market was the fastest growing market in the Asia-Pacific region. **Nuclear Imaging Equipment Devices Key Market Players & Competitive Insights** Leading market players are investing heavily in research and development in order to expand their product lines, which will help the nuclear imaging equipment devices market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their  footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, nuclear imaging equipment devices industry must offer cost-effective items. Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the  nuclear imaging equipment devices industry to benefit clients and increase the market sector. In recent years, the nuclear imaging equipment devices industry has offered some of the most significant advantages to medicine. Major players in the nuclear imaging equipment devices market are attempting to increase market demand by investing in research and development operations includes DIGIRAD Corporation, Neusoft Corporation, Bartec Technologies Ltd., BCL X-Ray Canada Inc., CANON MEDICAL SYSTEMS CORPORATION, CMR Naviscan, SurgicEye GmbH, TTG Imaging Solutions, LLC., Lucerno Dynamics LLC., Absolute Imaging Inc., Berthold Technologies GmbH & Co.KG, Incom Inc., Koninklijke Philips N.V., GE Healthcare, and Siemens Healthineers AG. Siemens Healthineers AG is a medical technology firm that designs, develops, produces, and sells minimally invasive procedure systems, clinical and workflow systems, and diagnostic imaging systems. Siemens Healthineers AG is a part of Siemens AG. The company's main offerings include [point-of-care (POC) testing](../../../reports/point-of-care-glucose-testing-market-12264) systems, mobile C-arms, hybrid ORs, angiography systems, ultrasound, computed tomography, magnetic resonance imaging, testing, and molecular imaging systems. Software platforms and industry solutions linked to product engineering are offered by Neusoft Corp. (Neusoft). Performance engineering, IT infrastructures, software localization and ization, enterprise applications, enterprise intelligent products, business process outsourcing, healthcare goods, platform products, application development and maintenance, and IT education and training services are all provided by the organization. Furthermore provided are industrial services, cloud, professional testing, software engineering, performance engineering, and product engineering services. **Key Companies in the nuclear imaging equipment devices market include** ### Nuclear Imaging Equipment Devices Market Industry Developments - **Q2 2024: QEII Health Sciences Centre becomes first in Canada to adopt GE HealthCare’s StarGuide SPECT/CT scanner** The QEII Health Sciences Centre in Nova Scotia became the inaugural Canadian health facility to install GE HealthCare’s StarGuide SPECT/CT nuclear medicine scanner, which features advanced 3-D imaging for improved diagnosis and treatment of cancer and heart conditions. - **Q4 2023: Siemens Healthineers receives FDA clearance for Biograph Vision.X PET/CT scanner** Siemens Healthineers announced FDA clearance for its Biograph Vision.X PET/CT scanner, which offers an industry-leading time of flight (TOF) of 178 picoseconds, making it the fastest TOF PET/CT scanner available. ## **Nuclear Imaging Equipment Devices Market Segmentation** ### **Nuclear Imaging Equipment Devices Product Outlook** ### **Nuclear Imaging Equipment Devices Application Outlook** ### **Nuclear Imaging Equipment Devices End-User Outlook** ### **Nuclear Imaging Equipment Devices Regional Outlook** ## Market Drivers ### Expansion of Healthcare Infrastructure The [Nuclear Imaging](https://www.marketresearchfuture.com/reports/nuclear-imaging-market-43091) Equipment Devices Market is positively impacted by the expansion of healthcare infrastructure in various regions. As healthcare facilities upgrade their diagnostic capabilities, the demand for advanced nuclear imaging devices is expected to rise. Investments in hospitals and diagnostic centers are increasing, particularly in emerging markets, where access to advanced medical technologies is becoming more widespread. This expansion is likely to create new opportunities for manufacturers and suppliers of nuclear imaging equipment, contributing to market growth. The overall healthcare expenditure is projected to increase, further supporting this trend. ### Growing Focus on Personalized Medicine The Nuclear Imaging Equipment Devices Market is witnessing a shift towards personalized medicine, which emphasizes tailored treatment plans based on individual patient profiles. Nuclear imaging technologies are integral to this approach, as they provide detailed insights into the biological processes of diseases. By enabling clinicians to visualize and understand the unique characteristics of a patient's condition, these devices facilitate more effective treatment strategies. The market is likely to benefit from this trend, as healthcare providers increasingly adopt nuclear imaging to enhance patient outcomes and optimize therapeutic interventions. ### Increasing Prevalence of Chronic Diseases The Nuclear Imaging Equipment Devices Market is significantly influenced by the rising prevalence of chronic diseases such as cancer and cardiovascular disorders. As these conditions become more common, the demand for effective diagnostic tools increases. Nuclear imaging plays a crucial role in the early detection and management of these diseases, allowing for timely interventions. According to recent statistics, the incidence of cancer is expected to rise by 30% in the next decade, further propelling the need for advanced nuclear imaging devices. This trend underscores the critical role of nuclear imaging in modern healthcare. ### Regulatory Support and Reimbursement Policies The Nuclear Imaging Equipment Devices Market benefits from favorable regulatory support and reimbursement policies that encourage the adoption of advanced imaging technologies. Governments and health organizations are increasingly recognizing the value of nuclear imaging in improving patient care and outcomes. As a result, reimbursement frameworks are evolving to cover a broader range of nuclear imaging procedures, making them more accessible to patients. This regulatory environment is likely to stimulate market growth, as healthcare providers are incentivized to invest in nuclear imaging equipment to enhance their diagnostic capabilities. ### Technological Advancements in Imaging Techniques The Nuclear Imaging Equipment Devices Market is experiencing a surge in technological advancements that enhance imaging techniques. Innovations such as [hybrid imaging](https://www.marketresearchfuture.com/reports/hybrid-imaging-market-32094) systems, which combine modalities like PET and CT, are becoming increasingly prevalent. These advancements not only improve diagnostic accuracy but also reduce patient exposure to radiation. The integration of artificial intelligence in image analysis is also gaining traction, potentially streamlining workflows and improving diagnostic outcomes. As a result, the market is projected to grow at a compound annual growth rate of approximately 7% over the next five years, driven by these technological improvements. ## Future Outlook The Nuclear Imaging Equipment Devices Market is projected to grow at a 5.5% CAGR from 2025 to 2035, driven by technological advancements, increasing healthcare expenditure, and rising demand for early disease detection. **New opportunities:** - Development of portable nuclear imaging devices for remote diagnostics. - Integration of AI for enhanced image analysis and interpretation. - Expansion into emerging markets with tailored product offerings. By 2035, the market is expected to achieve robust growth, positioning itself as a leader in diagnostic imaging. ## Segment Insights ### By Product: SPECT Imaging Systems (Largest) vs. PET Imaging Systems (Fastest-Growing) In the Nuclear Imaging Equipment Devices Market, SPECT imaging systems hold the largest market share, catering to a wide range of diagnostic needs in oncology, cardiology, and neurology. Within this segment, hybrid SPECT imaging systems are particularly favored due to their advanced capabilities that enhance diagnostic accuracy. Meanwhile, PET imaging systems are rapidly gaining traction, fueled by technological advancements and increasing utilization in cancer detection, thus emerging as a formidable contender in the market. SPECT Imaging Systems (Dominant) vs. PET Imaging Systems (Emerging) SPECT imaging systems are the cornerstone of the Nuclear Imaging Equipment Devices Market, known for their reliability and versatility in clinical settings. They allow healthcare providers to obtain critical insights into organ function and disease states. Conversely, PET imaging systems are positioned as an emerging technology, leveraging innovative imaging techniques to significantly improve early detection and treatment monitoring of various diseases, especially cancer. While SPECT systems dominate the traditional imaging landscape, the rapid adoption of PET technology indicates a shift towards more precise diagnostic methods. Factors such as regulatory support and rising patient demand for advanced imaging solutions will further streamline growth in both segments, but the PET systems' unique benefits position them for impressive future growth. ### By Application: Oncology (Largest) vs. Neurology (Fastest-Growing) In the Nuclear Imaging Equipment Devices Market, the application segment is primarily dominated by Oncology, capturing a significant share due to the prevalence of cancer and the rising demand for early diagnosis through advanced imaging techniques. Cardiology also holds a notable share, as nuclear imaging plays a crucial role in assessing heart conditions. Neurology and other applications are valuable segments but currently contribute less to the overall market share, reflecting growing awareness and advancements in imaging technologies. Oncology: Dominant vs. Neurology: Emerging Oncology continues to lead the Nuclear Imaging Equipment Devices Market as the dominant application due to the increasing incidence of cancer globally, along with the growing preference for personalized medicine. The advancements in imaging technologies, such as PET and SPECT, facilitate accurate diagnosis and treatment planning. In contrast, Neurology represents an emerging and rapidly growing application driven by an increasing focus on neurological disorders like Alzheimer's and Parkinson's disease. As healthcare providers seek to improve diagnostic accuracy and treatment efficacy for complex neurological conditions, the adoption of nuclear imaging technologies in this field is witnessing robust growth. ### By End-User: Hospitals (Largest) vs. Imaging Centers (Fastest-Growing) In the Nuclear Imaging Equipment Devices Market, the distribution of market share is heavily skewed towards hospitals, which account for a significant portion of the segment. Imaging centers, while smaller in comparison, are experiencing rapid adoption due to increasing demand for outpatient imaging services. Other end-users, including academic and research centers, also contribute to the total share but remain less dominant in the market landscape. Hospitals (Dominant) vs. Imaging Centers (Emerging) Hospitals hold a dominant position within the Nuclear Imaging Equipment Devices Market, attributed to their established infrastructure, comprehensive healthcare services, and the necessity for advanced diagnostic tools. The integration of nuclear imaging technologies aids in accurate disease diagnosis and monitoring, fostering reliance on these devices. Imaging centers, on the other hand, are emerging entities focusing on specialized nuclear imaging services, propelled by the growing trend towards outpatient care and accessibility. They are strategically positioned to cater to patients seeking convenience and expedited services, thus driving their rapid growth and adoption in the market. ## Regional Market Share Analysis ### North America : Healthcare Innovation Leader North America is the largest market for nuclear imaging equipment, holding approximately 45% of the global share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of chronic diseases, and significant investments in research and development. Regulatory support from agencies like the FDA further catalyzes market expansion, ensuring safety and efficacy in medical devices. The United States leads the market, with key players such as GE Healthcare and Medtronic dominating the landscape. Canada also contributes significantly, focusing on enhancing healthcare services. The competitive environment is characterized by continuous innovation and strategic partnerships among leading companies, ensuring a robust supply of advanced nuclear imaging technologies. ### Europe : Emerging Regulatory Frameworks Europe is the second-largest market for nuclear imaging equipment, accounting for about 30% of the global market share. The region's growth is fueled by an aging population, rising healthcare expenditures, and advancements in imaging technologies. Regulatory frameworks, particularly from the European Medicines Agency, are evolving to support innovation while ensuring patient safety, which is crucial for market expansion. Germany and France are the leading countries in this market, with significant contributions from Siemens Healthineers and Philips Healthcare. The competitive landscape is marked by a mix of established players and emerging startups, fostering innovation. Collaborative efforts among healthcare providers and technology firms are enhancing the availability and efficiency of nuclear imaging solutions across Europe. ### Asia-Pacific : Rapidly Growing Healthcare Sector Asia-Pacific is witnessing rapid growth in the nuclear imaging equipment market, holding approximately 20% of the global share. The region's expansion is driven by increasing healthcare investments, rising awareness of early disease detection, and a growing patient population. Countries like China and India are enhancing their healthcare infrastructure, supported by government initiatives aimed at improving medical services and technology adoption. China is the largest market in the region, with significant contributions from local manufacturers and international players like Canon Medical Systems. The competitive landscape is evolving, with a focus on affordability and accessibility of imaging technologies. Partnerships between healthcare providers and technology firms are crucial for advancing nuclear imaging capabilities in this diverse region. ### Middle East and Africa : Emerging Market Potential The Middle East and Africa represent a nascent but promising market for nuclear imaging equipment, accounting for about 5% of the global share. Growth is driven by increasing healthcare investments, rising incidences of chronic diseases, and a focus on improving diagnostic capabilities. Governments are prioritizing healthcare reforms, which are expected to enhance the adoption of advanced imaging technologies in the coming years. Countries like South Africa and the UAE are leading the market, with investments in healthcare infrastructure and technology. The competitive landscape is characterized by a mix of local and international players, including Bracco Imaging. Collaborative efforts between governments and private sectors are essential for fostering innovation and improving access to nuclear imaging solutions across the region. ## Competitive Benchmarking The Nuclear Imaging Equipment Devices Market is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for precise diagnostic tools. Major players such as GE Healthcare (US), Siemens Healthineers (DE), and Philips Healthcare (NL) are at the forefront, each adopting distinct strategies to enhance their market presence. GE Healthcare (US) focuses on innovation through the development of advanced imaging technologies, while Siemens Healthineers (DE) emphasizes strategic partnerships to expand its product offerings. Philips Healthcare (NL) is actively pursuing digital transformation initiatives, integrating AI capabilities into its imaging devices, thereby enhancing diagnostic accuracy and operational efficiency. Collectively, these strategies contribute to a competitive environment that is increasingly centered around technological innovation and collaborative growth. In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance operational efficiency and reduce costs. The market structure appears moderately fragmented, with several key players exerting considerable influence. This fragmentation allows for a diverse range of products and services, catering to various customer needs while fostering competition among established and emerging players. In August 2025, Siemens Healthineers (DE) announced a strategic partnership with a leading AI firm to develop next-generation imaging solutions. This collaboration aims to leverage AI algorithms to improve image quality and reduce scan times, which could significantly enhance patient outcomes. The strategic importance of this partnership lies in its potential to position Siemens Healthineers as a leader in the integration of AI within nuclear imaging, thereby attracting a broader customer base. In September 2025, GE Healthcare (US) launched a new line of portable nuclear imaging devices designed for use in remote and underserved areas. This initiative not only addresses the growing demand for accessible healthcare solutions but also aligns with global health initiatives aimed at improving diagnostic capabilities in low-resource settings. The launch underscores GE Healthcare's commitment to innovation and its strategic focus on expanding its market reach. In October 2025, Philips Healthcare (NL) unveiled a comprehensive digital platform that integrates its imaging devices with cloud-based analytics. This platform aims to streamline workflows and enhance data sharing among healthcare providers. The strategic significance of this development lies in its potential to foster collaborative care models, ultimately improving patient management and outcomes. As of October 2025, current competitive trends in the Nuclear Imaging Equipment Devices Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming pivotal in shaping the landscape, as companies seek to combine their strengths to innovate and respond to evolving market demands. Looking ahead, competitive differentiation is likely to shift from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability, as companies strive to meet the growing expectations of healthcare providers and patients alike. ## Recent News & Developments - **Q2 2024: QEII Health Sciences Centre becomes first in Canada to adopt GE HealthCare’s StarGuide SPECT/CT scanner** The QEII Health Sciences Centre in Nova Scotia became the inaugural Canadian health facility to install GE HealthCare’s StarGuide SPECT/CT nuclear medicine scanner, which features advanced 3-D imaging for improved diagnosis and treatment of cancer and heart conditions. - **Q4 2023: Siemens Healthineers receives FDA clearance for Biograph Vision.X PET/CT scanner** Siemens Healthineers announced FDA clearance for its Biograph Vision.X PET/CT scanner, which offers an industry-leading time of flight (TOF) of 178 picoseconds, making it the fastest TOF PET/CT scanner available. ## Report Scope | MARKET SIZE 2024 | 3.112(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 3.284(USD Billion) | | MARKET SIZE 2035 | 5.61(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.5% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Elekta (SE), Medtronic (US), Hitachi Medical Corporation (JP), Bracco Imaging (IT) | | Segments Covered | Product, Application, End-User, Region | | Key Market Opportunities | Advancements in artificial intelligence enhance diagnostic accuracy in the Nuclear Imaging Equipment Devices Market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the Nuclear Imaging Equipment Devices market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the projected market valuation of the Nuclear Imaging Equipment Devices Market by 2035?** A: The projected market valuation for the Nuclear Imaging Equipment Devices Market is expected to reach 5.61 USD Billion by 2035. **Q: What was the overall market valuation of the Nuclear Imaging Equipment Devices Market in 2024?** A: The overall market valuation of the Nuclear Imaging Equipment Devices Market was 3.112 USD Billion in 2024. **Q: What is the expected CAGR for the Nuclear Imaging Equipment Devices Market during the forecast period 2025 - 2035?** A: The expected CAGR for the Nuclear Imaging Equipment Devices Market during the forecast period 2025 - 2035 is 5.5%. **Q: Which companies are considered key players in the Nuclear Imaging Equipment Devices Market?** A: Key players in the Nuclear Imaging Equipment Devices Market include GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems. **Q: What are the projected revenues for SPECT Imaging Systems by 2035?** A: The projected revenues for SPECT Imaging Systems are expected to reach 1.68 USD Billion by 2035. **Q: How does the market for PET Imaging Systems compare to that of Hybrid SPECT Imaging Systems by 2035?** A: By 2035, the market for PET Imaging Systems is projected to reach 1.68 USD Billion, while Hybrid SPECT Imaging Systems is expected to reach 1.12 USD Billion. **Q: What is the anticipated growth in the oncology application segment of the Nuclear Imaging Equipment Devices Market by 2035?** A: The oncology application segment is projected to grow to 1.68 USD Billion by 2035. **Q: What is the expected market size for hospitals as end-users of Nuclear Imaging Equipment Devices by 2035?** A: The expected market size for hospitals as end-users is projected to reach 2.8 USD Billion by 2035. **Q: What revenue growth is anticipated for imaging centers in the Nuclear Imaging Equipment Devices Market by 2035?** A: The revenue for imaging centers is expected to grow to 1.6 USD Billion by 2035. **Q: What is the projected market size for standalone SPECT Imaging Systems by 2035?** A: The projected market size for standalone SPECT Imaging Systems is expected to reach 0.83 USD Billion by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/nuclear-imaging-equipment-devices-market-16070*